VIKING GLOBAL PERFORMANCE LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for VIKING GLOBAL PERFORMANCE LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of VIKING GLOBAL PERFORMANCE LLC. VIKING GLOBAL PERFORMANCE LLC is 10% Owner in Arbutus Biopharma Corp ($TKMR) and 10% Owner in Adaptive Biotechnologies Corp ($ADPT) and 10% Owner in Axovant Sciences Ltd. ($AXON) and 10% Owner in Editas Medicine, Inc. ($EDIT) and 10% Owner in Myovant Sciences Ltd. ($MYOV) and 10% Owner in BridgeBio Pharma, Inc. ($BBIO) and 10% Owner in Urovant Sciences Ltd. ($UROV).
Latest Insider Trading Transactions of VIKING GLOBAL PERFORMANCE LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADPT, TKMR, BBIO, EDIT, MYOV, AXON, UROV
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Sell | S | 49.52 | 2,500,000 | 123,787,500 | 30,993,708 | 33.5 M to 31 M (-7.46 %) |
| Jan 30 2020 | ADPT | Adaptive Biotechno ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Sell | S | 24.98 | 4,912,899 | 122,706,039 | 33,493,708 | 38.4 M to 33.5 M (-12.79 %) |
| Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Option Exercise | C | 0.00 | 50,446,451 | 0 | 0 | |
| Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Option Exercise | C | 0.00 | 51,781,276 | 0 | 0 | |
| Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 17.00 | 4,705,900 | 80,000,300 | 26,620,991 | 21.9 M to 26.6 M (+21.47 %) |
| Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | C | 0.00 | 10,178,954 | 0 | 21,915,091 | 11.7 M to 21.9 M (+86.73 %) |
| Jun 28 2019 | BBIO | BridgeBio Pharma, ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | C | 0.00 | 11,736,137 | 0 | 11,736,137 | 0 to 11.7 M |
| Jun 19 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.17 | 4,957 | 40,495 | 22,860,013 | 22.9 M to 22.9 M (+0.02 %) |
| Jun 19 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.21 | 6,706 | 55,061 | 22,855,056 | 22.8 M to 22.9 M (+0.03 %) |
| Jun 19 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.53 | 6,541 | 55,825 | 22,848,350 | 22.8 M to 22.8 M (+0.03 %) |
| Jun 14 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.91 | 7,144 | 56,514 | 22,841,809 | 22.8 M to 22.8 M (+0.03 %) |
| Jun 14 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.95 | 7,367 | 58,543 | 22,834,665 | 22.8 M to 22.8 M (+0.03 %) |
| Jun 14 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.30 | 7,500 | 62,244 | 22,827,298 | 22.8 M to 22.8 M (+0.03 %) |
| Jun 13 2019 | MYOV | Myovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.25 | 2,424,242 | 19,999,997 | 40,765,599 | 38.3 M to 40.8 M (+6.32 %) |
| Jun 11 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.58 | 7,189 | 61,694 | 22,819,798 | 22.8 M to 22.8 M (+0.03 %) |
| Jun 11 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.35 | 7,500 | 62,594 | 22,812,609 | 22.8 M to 22.8 M (+0.03 %) |
| Jun 11 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.97 | 6,649 | 52,959 | 22,805,109 | 22.8 M to 22.8 M (+0.03 %) |
| Jun 06 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.00 | 7,082 | 56,621 | 22,798,460 | 22.8 M to 22.8 M (+0.03 %) |
| Jun 06 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.02 | 6,540 | 52,418 | 22,791,378 | 22.8 M to 22.8 M (+0.03 %) |
| Jun 06 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.59 | 7,500 | 56,911 | 22,784,838 | 22.8 M to 22.8 M (+0.03 %) |
| Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.71 | 5,424 | 41,815 | 22,777,338 | 22.8 M to 22.8 M (+0.02 %) |
| Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.70 | 5,071 | 39,042 | 22,771,914 | 22.8 M to 22.8 M (+0.02 %) |
| Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.91 | 300 | 2,672 | 22,766,843 | 22.8 M to 22.8 M (0.00 %) |
| Jun 03 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.97 | 6,951 | 55,418 | 22,766,543 | 22.8 M to 22.8 M (+0.03 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
| May 29 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
| May 23 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 0 | -1,715 to 0 (-100.00 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 0 | -8,285 to 0 (-100.00 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 0 | -6,200 to 0 (-100.00 %) |
| May 20 2019 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
| Mar 19 2019 | AXON | Axovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 1.50 | 6,666,667 | 10,000,001 | 105,952,381 | 99.3 M to 106 M (+6.71 %) |
| Dec 20 2018 | AXON | Axovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 1.00 | 10,000,000 | 10,000,000 | 99,285,714 | 89.3 M to 99.3 M (+11.20 %) |
| Oct 03 2018 | UROV | Urovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 14.00 | 2,678,571 | 37,499,994 | 22,703,669 | 20 M to 22.7 M (+13.38 %) |
| Jun 07 2018 | AXON | Axovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 1.75 | 14,285,714 | 25,000,000 | 89,285,714 | 75 M to 89.3 M (+19.05 %) |
| Apr 04 2018 | MYOV | Myovant Sciences L ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 20.27 | 1,110,015 | 22,500,004 | 38,341,357 | 37.2 M to 38.3 M (+2.98 %) |
| Jan 16 2018 | TKMR | Arbutus Biopharma ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Option Exercise | P | 7.13 | 664,000 | 4,734,320 | 1,164,000 | |
| Oct 17 2017 | TKMR | Arbutus Biopharma ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Option Exercise | P | 7.13 | 500,000 | 3,565,000 | 500,000 | |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Option Exercise | C | 0.00 | 4,444,444 | 0 | 0 | |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Option Exercise | C | 0.00 | 4,444,444 | 0 | 0 | |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 5,335 | 0 | 266,782 | 261.4 K to 266.8 K (+2.04 %) |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 261,447 | 0 | 261,447 | 0 to 261.4 K |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 481,567 | 0 | 481,567 | 0 to 481.6 K |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 15,072 | 0 | 15,072 | 0 to 15.1 K |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 256,986 | 0 | 256,986 | 0 to 257 K |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | C | 0.00 | 1,709,401 | 0 | 1,709,401 | 0 to 1.7 M |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 20,407 | 0 | 2,729,808 | 2.7 M to 2.7 M (+0.75 %) |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 1,000,000 | 0 | 2,709,401 | 1.7 M to 2.7 M (+58.50 %) |
| Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | C | 0.00 | 1,709,401 | 0 | 1,709,401 | 0 to 1.7 M |
Page: 1